Truth and science matter. Support both. Professor and Chair of Urology - UCLA
Los Angeles
Joined February 2013
- Tweets3.1K
- Following402
- Followers6.7K
- Likes9.2K
If goal is to minimize unnecessary treatment of GG1, empiric data from Australia shows nomenclature change AND information/messaging supplement each other
Editorial by @VickersBiostats: academic.oup.com/jnci/advanc…
academic.oup.com/jnci/articl…
@RenuEapen @declangmurphy @GladellPaner
UCLA Urology has a long history of impactful basic science discoveries, clinical innovation, practice-changing trials, FDA drug/imaging approvals, and mentorship of future leaders.
We are hiring a Vice-Chair of Research: recruit.apo.ucla.edu/JPF1131…
DM if questions/nominations
In a place presumably guided by science (or at least common sense), let's call out the crazy:
- surgeons with shaved heads wearing mandatory caps
- people nowhere near the sterile field wearing ridiculously fitted beard condoms
What else?
An essay worth reading, for every clinician and patient (with a PrCa paragraph)
The Quiet Half of Good Medicine jamanetwork.com/journals/jam…
Scott Eggener retweeted
🚨 New in @JUrology: "Language as a powerful influencer in #ProstateCancer" 🚨
✒️ New essay w/ @uroegg & Jessica Rett @LinguisticsUcla
📄 Words are neither neutral nor fixed
♋️We use prostate cancer, a disease spanning indolent to lethal under one name, as a case study:
👉 MRI "lesion"
👉 clinically "significant" disease
👉 "positive" margin
❓ We all know these terms shape how patients hear us
🧵 5 strategies you can use today 👇
A prolific prostate cancer clinician-scientist leans on his undergrad English degree with a long-form thoughtful piece on 'cancer' nomenclature
When "cancer" is a diagnosis but not really a disease
A slightly more philosophical piece than my usual—on what we mean by cancer, and whether the word itself can sometimes do more harm than good.... let me know what you think!
Many thanks @pam3001 @aeonmag
aeon.co/essays/we-need-a-bet…
Yet another positive diet, exercise, lifestyle trial....for men on ADT at high-risk of toxicity.
The STAMINA RCT - thelancet.com/journals/lanon…
Essential for all physicians and surgeons to be aware of new policy from Jehovah's Witnesses
jw.org/finder?wtlocale=E&doc…
Scott Eggener retweeted
Scott, you know where I stand on this. Molecular features don’t matter when clinical characteristics are BENIGN. Let’s be pragmatic. Patients don’t understand. I think this would be a great topic for the plenary at the AUA annual meeting. 😉 @AmerUrological
"GG1 shares molecular features with higher grade cancer, we must call it cancer"
"Great point, let's look into it"
Every one also present in benign and pre cancers, fairly certain we shouldn't call those cancers
QED to that counterargument
bjui-journals.onlinelibrary.…
Set your precons aside, read this, and buckle up!!
jamanetwork.com/journals/jam…
How cool is this? Closer to the holy grail of immunosuppression-free solid organ transplant, spearheaded by one of our urologists: Jeff Veale
A first of its kind organ transplant technique tried on a human subject nbcnews.com/video/a-first-of… via @nbcnews @UclaUrology
Release the hounds......try to stay civil folks
@TylerSbrt @AbhinavSidana @EmbertonMark @daviesbj
statnews.com/2026/08/21/foca…
Yet again, the VA aspirationally showing us how prostate cancer should be managed!
jamanetwork.com/journals/jam…
@dr_coops
Great study. Need more of these
My kinda sorta version of this: "try tamsulosin for a few weeks; if it isn't helping, stop it"
Tamsulosin Deprescribing for Tamsulosin Deprescribing for Lower Urinary Tract Symptoms in Older Men jamanetwork.com/journals/jam…
Yet another reminder that thoughtful PrCa screening, risk-based management, and equal access can have tremendous value for individual and population health
The more we minimize overDx and overRx, the more men will be screened and have their lives saved
jamanetwork.com/journals/jam…
This will definitely stimulate some debate....and should
Surgeon Sleep Patterns and Patient Risk of Major Adverse Events jamanetwork.com/journals/jam…
First ever locally injectable immunoactive agent with proven DFS benefit in localized prostate cancer.
Tandem randomized Phase II in surveillance forthcoming.
Origin: Baylor basic science lab (support research!)
thelancet.com/journals/lanon…
The Influence of Urology on Longevity
JAMA article from 1926: vaccines, clean water, and Urology (?!?!) responsible for dramatic lengthening of life expectancy
jamanetwork.com/journals/jam…